XOMA ROYALTY CORPORATION (XOMA) Fundamental Analysis & Valuation

NASDAQ:XOMA • US98419J2069

Current stock price

26.38 USD
-0.48 (-1.79%)
At close:
27 USD
+0.62 (+2.35%)
After Hours:

This XOMA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. XOMA Profitability Analysis

1.1 Basic Checks

  • In the past year XOMA was profitable.
  • In the past year XOMA had a positive cash flow from operations.
  • In multiple years XOMA reported negative net income over the last 5 years.
  • In multiple years XOMA reported negative operating cash flow during the last 5 years.
XOMA Yearly Net Income VS EBIT VS OCF VS FCFXOMA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M

1.2 Ratios

  • The Return On Assets of XOMA (3.75%) is better than 89.60% of its industry peers.
  • XOMA has a better Return On Equity (9.14%) than 92.29% of its industry peers.
  • With an excellent Return On Invested Capital value of 3.31%, XOMA belongs to the best of the industry, outperforming 89.79% of the companies in the same industry.
Industry RankSector Rank
ROA 3.75%
ROE 9.14%
ROIC 3.31%
ROA(3y)-14.85%
ROA(5y)-6.52%
ROE(3y)-31.32%
ROE(5y)-15.58%
ROIC(3y)N/A
ROIC(5y)N/A
XOMA Yearly ROA, ROE, ROICXOMA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 400 600 800 1K

1.3 Margins

  • XOMA has a better Profit Margin (20.96%) than 93.45% of its industry peers.
  • XOMA has a better Operating Margin (20.92%) than 94.22% of its industry peers.
Industry RankSector Rank
OM 20.92%
PM (TTM) 20.96%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
XOMA Yearly Profit, Operating, Gross MarginsXOMA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. XOMA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), XOMA is destroying value.
  • Compared to 1 year ago, XOMA has more shares outstanding
  • XOMA has more shares outstanding than it did 5 years ago.
  • XOMA has a worse debt/assets ratio than last year.
XOMA Yearly Shares OutstandingXOMA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
XOMA Yearly Total Debt VS Total AssetsXOMA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

  • Based on the Altman-Z score of -4.49, we must say that XOMA is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of -4.49, XOMA is not doing good in the industry: 61.46% of the companies in the same industry are doing better.
  • XOMA has a Debt/Equity ratio of 0.87. This is a neutral value indicating XOMA is somewhat dependend on debt financing.
  • The Debt to Equity ratio of XOMA (0.87) is worse than 73.22% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.87
Debt/FCF N/A
Altman-Z -4.49
ROIC/WACC0.36
WACC9.12%
XOMA Yearly LT Debt VS Equity VS FCFXOMA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

  • XOMA has a Current Ratio of 3.91. This indicates that XOMA is financially healthy and has no problem in meeting its short term obligations.
  • With a Current ratio value of 3.91, XOMA perfoms like the industry average, outperforming 46.24% of the companies in the same industry.
  • A Quick Ratio of 3.91 indicates that XOMA has no problem at all paying its short term obligations.
  • XOMA's Quick ratio of 3.91 is in line compared to the rest of the industry. XOMA outperforms 48.36% of its industry peers.
Industry RankSector Rank
Current Ratio 3.91
Quick Ratio 3.91
XOMA Yearly Current Assets VS Current LiabilitesXOMA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. XOMA Growth Analysis

3.1 Past

  • XOMA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 135.71%, which is quite impressive.
  • The Revenue has grown by 103.96% in the past year. This is a very strong growth!
  • The Revenue has been growing by 9.17% on average over the past years. This is quite good.
EPS 1Y (TTM)135.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%144.03%
Revenue 1Y (TTM)103.96%
Revenue growth 3Y-9.28%
Revenue growth 5Y9.17%
Sales Q2Q%29.93%

3.2 Future

  • Based on estimates for the next years, XOMA will show a very strong growth in Earnings Per Share. The EPS will grow by 37.32% on average per year.
  • The Revenue is expected to grow by 40.77% on average over the next years. This is a very strong growth
EPS Next Y157.93%
EPS Next 2Y46.72%
EPS Next 3Y37.32%
EPS Next 5YN/A
Revenue Next Year73.27%
Revenue Next 2Y49.67%
Revenue Next 3Y33.49%
Revenue Next 5Y40.77%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
XOMA Yearly Revenue VS EstimatesXOMA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 100M 200M 300M
XOMA Yearly EPS VS EstimatesXOMA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -2 -4 -6 -8 -10

More info and screens

Find the best growth stocksShow best growing peers

4

4. XOMA Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 35.17 indicates a quite expensive valuation of XOMA.
  • Compared to the rest of the industry, the Price/Earnings ratio of XOMA indicates a rather cheap valuation: XOMA is cheaper than 91.33% of the companies listed in the same industry.
  • XOMA's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 25.70.
  • Based on the Price/Forward Earnings ratio of 83.90, the valuation of XOMA can be described as expensive.
  • Based on the Price/Forward Earnings ratio, XOMA is valued cheaper than 88.82% of the companies in the same industry.
  • XOMA's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 23.84.
Industry RankSector Rank
PE 35.17
Fwd PE 83.9
XOMA Price Earnings VS Forward Price EarningsXOMA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • XOMA's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. XOMA is cheaper than 91.91% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 32.36
XOMA Per share dataXOMA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

  • XOMA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • XOMA's earnings are expected to grow with 37.32% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.22
PEG (5Y)N/A
EPS Next 2Y46.72%
EPS Next 3Y37.32%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. XOMA Dividend Analysis

5.1 Amount

  • No dividends for XOMA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

XOMA Fundamentals: All Metrics, Ratios and Statistics

XOMA ROYALTY CORPORATION

NASDAQ:XOMA (3/13/2026, 8:04:07 PM)

After market: 27 +0.62 (+2.35%)

26.38

-0.48 (-1.79%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-12
Earnings (Next)03-18
Inst Owners70.51%
Inst Owner Change3.14%
Ins Owners1.79%
Ins Owner Change6.58%
Market Cap326.58M
Revenue(TTM)47.11M
Net Income(TTM)9.87M
Analysts81.82
Price Target65.79 (149.39%)
Short Float %11.15%
Short Ratio2.96
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0.47
Dividend Growth(5Y)N/A
DP55.43%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1055.58%
Min EPS beat(2)295.48%
Max EPS beat(2)1815.69%
EPS beat(4)3
Avg EPS beat(4)546.36%
Min EPS beat(4)-45.44%
Max EPS beat(4)1815.69%
EPS beat(8)4
Avg EPS beat(8)287.41%
EPS beat(12)5
Avg EPS beat(12)186.43%
EPS beat(16)6
Avg EPS beat(16)118.77%
Revenue beat(2)1
Avg Revenue beat(2)6.32%
Min Revenue beat(2)-20.06%
Max Revenue beat(2)32.7%
Revenue beat(4)2
Avg Revenue beat(4)32.77%
Min Revenue beat(4)-20.06%
Max Revenue beat(4)120.82%
Revenue beat(8)5
Avg Revenue beat(8)16.19%
Revenue beat(12)7
Avg Revenue beat(12)15.39%
Revenue beat(16)8
Avg Revenue beat(16)0.85%
PT rev (1m)0%
PT rev (3m)-8.73%
EPS NQ rev (1m)0%
EPS NQ rev (3m)11.76%
EPS NY rev (1m)0%
EPS NY rev (3m)7.67%
Revenue NQ rev (1m)-0.72%
Revenue NQ rev (3m)-0.46%
Revenue NY rev (1m)-0.2%
Revenue NY rev (3m)-0.17%
Valuation
Industry RankSector Rank
PE 35.17
Fwd PE 83.9
P/S 6.93
P/FCF N/A
P/OCF 59.72
P/B 3.03
P/tB 5.15
EV/EBITDA 32.36
EPS(TTM)0.75
EY2.84%
EPS(NY)0.31
Fwd EY1.19%
FCF(TTM)-1.19
FCFYN/A
OCF(TTM)0.44
OCFY1.67%
SpS3.81
BVpS8.72
TBVpS5.12
PEG (NY)0.22
PEG (5Y)N/A
Graham Number12.13
Profitability
Industry RankSector Rank
ROA 3.75%
ROE 9.14%
ROCE 4.2%
ROIC 3.31%
ROICexc 4.14%
ROICexgc 5.42%
OM 20.92%
PM (TTM) 20.96%
GM N/A
FCFM N/A
ROA(3y)-14.85%
ROA(5y)-6.52%
ROE(3y)-31.32%
ROE(5y)-15.58%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.18
Health
Industry RankSector Rank
Debt/Equity 0.87
Debt/FCF N/A
Debt/EBITDA 7.77
Cap/Depr 880.03%
Cap/Sales 42.84%
Interest Coverage 0.83
Cash Conversion 45.03%
Profit Quality N/A
Current Ratio 3.91
Quick Ratio 3.91
Altman-Z -4.49
F-Score6
WACC9.12%
ROIC/WACC0.36
Cap/Depr(3y)7738.51%
Cap/Depr(5y)4653.1%
Cap/Sales(3y)108.05%
Cap/Sales(5y)64.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)135.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%144.03%
EPS Next Y157.93%
EPS Next 2Y46.72%
EPS Next 3Y37.32%
EPS Next 5YN/A
Revenue 1Y (TTM)103.96%
Revenue growth 3Y-9.28%
Revenue growth 5Y9.17%
Sales Q2Q%29.93%
Revenue Next Year73.27%
Revenue Next 2Y49.67%
Revenue Next 3Y33.49%
Revenue Next 5Y40.77%
EBIT growth 1Y152.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year144.59%
EBIT Next 3Y48.37%
EBIT Next 5YN/A
FCF growth 1Y55.92%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y130.18%
OCF growth 3YN/A
OCF growth 5YN/A

XOMA ROYALTY CORPORATION / XOMA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for XOMA ROYALTY CORPORATION?

ChartMill assigns a fundamental rating of 5 / 10 to XOMA.


What is the valuation status for XOMA stock?

ChartMill assigns a valuation rating of 4 / 10 to XOMA ROYALTY CORPORATION (XOMA). This can be considered as Fairly Valued.


How profitable is XOMA ROYALTY CORPORATION (XOMA) stock?

XOMA ROYALTY CORPORATION (XOMA) has a profitability rating of 5 / 10.


How financially healthy is XOMA ROYALTY CORPORATION?

The financial health rating of XOMA ROYALTY CORPORATION (XOMA) is 3 / 10.


What is the earnings growth outlook for XOMA ROYALTY CORPORATION?

The Earnings per Share (EPS) of XOMA ROYALTY CORPORATION (XOMA) is expected to grow by 157.93% in the next year.